Impact of Achieved Blood Pressures on Mortality Risk and End-Stage Renal Disease Among a Large, Diverse Hypertension Population

被引:114
作者
Sim, John J. [1 ]
Shi, Jiaxiao [2 ]
Kovesdy, Csaba P. [3 ]
Kalantar-Zadeh, Kamyar [4 ]
Jacobsen, Steven J. [2 ]
机构
[1] Kaiser Permanente, Los Angeles Med Ctr, Div Nephrol & Hypertens, Los Angeles, CA USA
[2] Kaiser Permanente So Calif, Dept Res & Evaluat, Los Angeles, CA 90027 USA
[3] Memphis VA Med Ctr, Memphis, TN USA
[4] Univ Calif Irvine, Med Ctr, Div Nephrol & Hypertens, Harold Simmons Ctr Kidney Dis Res & Epidemiol, Orange, CA USA
基金
美国国家卫生研究院;
关键词
blood pressure goals; hypertension treatment; mortality risk; renal failure risk; treatment risk; ISOLATED SYSTOLIC HYPERTENSION; CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR EVENTS; METAANALYSIS; OUTCOMES; TARGETS; HEALTH; ADULTS; OLDER; PREVALENCE;
D O I
10.1016/j.jacc.2014.04.065
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Medical data or clinical guidelines have not adequately addressed the ideal blood pressure (BP) treatment targets for survival and renal outcome. OBJECTIVES This study sought to evaluate ranges of treated BP in a large hypertension population and compare risk of mortality and end-stage renal disease (ESRD). METHODS A retrospective cohort study within the Kaiser Permanente Southern California health system was performed from January 1, 2006, to December 31, 2010. Treated hypertensive subjects >= 18 years of age were studied. Cox proportional hazards regression models were used to evaluate the risks (hazard ratios) for mortality and/or ESRD among different BP categories with and without stratification for diabetes mellitus and older age. RESULTS Among 398,419 treated hypertensive subjects (30% with diabetes mellitus), mortality occurred in 25,182 (6.3%) and ESRD in 4,957 (1.2%). Adjusted hazard ratios (95% confidence intervals [CI]) for composite mortality/ESRD in systolic BP <110, 110 to 119, 120 to 129, 140 to 149, 150 to 159, 160 to 169, and >= 170 compared with 130 to 139 mm Hg were 4.1 (95% CI: 3.8 to 1.3), 1.8 (95% CI: 1.7 to 1.9), 1.1 (95% CI: 1.1 to 1.1), 1.4 (95% CI: 1.4 to 1.5), 2.3 (95% CI: 2.2 to 2.5), 3.3 (95% CI: 3.0 to 3.6), and 4.9 (95% CI: 4.4 to 5.5) respectively. Diastolic BP 60 to 79 mm Hg were associated with the lowest risk. The nadir systolic and diastolic BP for the lowest risk was 137 and 71 mm Hg, respectively. Stratified analyses revealed that the diabetes mellitus population had a similar hazard ratio curve but a lower nadir at 131 and 69 mm Hg but age >= 70 had a higher nadir (140 and 70 mm Hg). CONCLUSIONS Both higher and lower treated BP compared with 130 to 139 mm Hg systolic and 60 to 79 mm Hg diastolic ranges had worsened outcomes. Our study adds to the growing uncertainty about BP treatment targets. (C) 2014 by the American College of Cardiology Foundation.
引用
收藏
页码:588 / 597
页数:10
相关论文
共 41 条
[1]  
[Anonymous], 1991, JAMA, V265, P3255
[2]   EFFECTS OF TREATMENT ON MORBIDITY IN HYPERTENSION - RESULTS IN PATIENTS WITH DIASTOLIC BLOOD PRESSURES AVERAGING 115 THROUGH 129 MM HG [J].
不详 .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1967, 202 (11) :1028-&
[3]   Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease [J].
Appel, Lawrence J. ;
Wright, Jackson T., Jr. ;
Greene, Tom ;
Agodoa, Lawrence Y. ;
Astor, Brad C. ;
Bakris, George L. ;
Cleveland, William H. ;
Charleston, Jeanne ;
Contreras, Gabriel ;
Faulkner, Marquetta L. ;
Gabbai, Francis B. ;
Gassman, Jennifer J. ;
Hebert, Lee A. ;
Jamerson, Kenneth A. ;
Kopple, Joel D. ;
Kusek, John W. ;
Lash, James P. ;
Lea, Janice P. ;
Lewis, Julia B. ;
Lipkowitz, Michael S. ;
Massry, Shaul G. ;
Miller, Edgar R. ;
Norris, Keith ;
Phillips, Robert A. ;
Pogue, Velvie A. ;
Randall, Otelio S. ;
Rostand, Stephen G. ;
Smogorzewski, Miroslaw J. ;
Toto, Robert D. ;
Wang, Xuelei .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (10) :918-929
[4]   J-curve revisited: an analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial† [J].
Bangalore, Sripal ;
Messerli, Franz H. ;
Wun, Chuan-Chuan ;
Zuckerman, Andrea L. ;
DeMicco, David ;
Kostis, John B. ;
LaRosa, John C. .
EUROPEAN HEART JOURNAL, 2010, 31 (23) :2897-2908
[5]   Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial [J].
Benavente, O. R. ;
Coffey, C. S. ;
Conwit, R. ;
Hart, R. G. ;
McClure, L. A. ;
Pearce, L. A. ;
Pergola, P. E. ;
Szychowski, J. M. ;
Benavente, O. R. ;
Hart, R. G. ;
Pergola, P. E. ;
Palacio, S. ;
Castro, I. ;
Farias, A. ;
Roldan, A. ;
Kase, C. ;
Gavras, I. ;
Lau, H. ;
Ogrodnik, M. ;
Allen, N. ;
Meissner, I. ;
Graves, J. ;
Herzig, D. ;
Covalt, J. ;
Meyer, B. ;
Jackson, C. ;
Gamble, P. ;
Kelly, N. ;
Warner, J. ;
Bell, J. ;
Demaerschalk, B. ;
Hogan, M. ;
Wochos, D. ;
Wieser, J. ;
Cleary, B. ;
Wood, L. ;
Hanna, J. ;
Zipp, T. ;
Bailey, S. ;
Cook, D. ;
Liskay, A. ;
Simcox, D. ;
Kappler, J. ;
Anderson, D. ;
Grimm, R. ;
Brauer, D. ;
Pettigrew, C. ;
Vaishnov, A. ;
Sawaya, P. ;
Fowler, A. .
LANCET, 2013, 382 (9891) :507-515
[6]   25-Hydroxyvitamin D Levels and Hypertension Rates [J].
Bhandari, Simran K. ;
Pashayan, Shahe ;
Liu, In Lu A. ;
Rasgon, Scott A. ;
Kujubu, Dean A. ;
Tom, Thomas Y. ;
Sim, John J. .
JOURNAL OF CLINICAL HYPERTENSION, 2011, 13 (03) :170-177
[7]   Tight Blood Pressure Control and Cardiovascular Outcomes Among Hypertensive Patients With Diabetes and Coronary Artery Disease [J].
Cooper-DeHoff, Rhonda M. ;
Gong, Yan ;
Handberg, Eileen M. ;
Bavry, Anthony A. ;
Denardo, Scott J. ;
Bakris, George L. ;
Pepine, Carl J. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (01) :61-68
[8]   Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus [J].
Cushman, William C. ;
Evans, Gregory W. ;
Byington, Robert P. ;
Goff, David C., Jr. ;
Grimm, Richard H., Jr. ;
Cutler, Jeffrey A. ;
Simons-Morton, Denise G. ;
Basile, Jan N. ;
Corson, Marshall A. ;
Probstfield, Jeffrey L. ;
Katz, Lois ;
Peterson, Kevin A. ;
Friedewald, William T. ;
Buse, John B. ;
Bigger, J. Thomas ;
Gerstein, Hertzel C. ;
Ismail-Beigi, Faramarz .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (17) :1575-1585
[9]   Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rates in United States Adults Between 1988-1994 and 1999-2004 [J].
Cutler, Jeffrey A. ;
Sorlie, Paul D. ;
Wolz, Michael ;
Thom, Thomas ;
Fields, Larry E. ;
Roccella, Edward J. .
HYPERTENSION, 2008, 52 (05) :818-827
[10]   The risks associated with short-term placebo-controlled antihypertensive clinical trials: a descriptive meta-analysis [J].
DeFelice, A. ;
Willard, J. ;
Lawrence, J. ;
Hung, J. ;
Gordon, M. A. ;
Karkowsky, A. ;
Targum, S. ;
Throckmorton, D. C. ;
Girton, J. ;
Stertz, B. ;
Glasser, S. P. ;
Lipicky, R. J. .
JOURNAL OF HUMAN HYPERTENSION, 2008, 22 (10) :659-668